Swedish digital health start-up Doktor.se secures a further €29.5 million for the global expansion of its services.

The startup Stockholm-based Doktor.se has secured €29.5 million in funding from Chinese technology group Tencent Holdings. Of the total amount raised, €23 million will be new capital and €6.5 million will come from existing shareholders, to be operating in more than seven countries by end of 2021. The funding comes in the form of an […]

SWORD Health secures $85 million in Series C funding to further boost its digital MSK offering

Earlier this month, digital musculoskeletal care startup SWORD Health announced $85 million in Series C funding that will go toward continued growth of its digital solution. The announcement comes about six months after the company closed its $25 million Series B funding round. Led by General Catalyst with participation from BOND, Highmark Ventures, BPEA, Khosla […]

Pear Therapeutics to go public in a $1.6 billion SPAC transaction to expand its DTx offering

Pear Therapeutics announced plans to go public by merging with Thimble Point Acquisition Corp. in a $1.6 billion special purpose acquisition company (SPAC). The company said the move is expected to facilitate commercialisation and expansion. According to the announcement, the newly merged company will operate under the name Pear Holding Corp and will be listed […]

Thymia raises $1.1m for video game-inspired tool to assess and track depression

Thymia has raised a £780k/$1.1m pre-seed round to scale its platform to assess for and monitor depression. The Thymia technology removes the subjectivity from mental health assessments: instead of answering questionnaires, patients play specially designed video games which use cutting-edge Neuropsychology, Linguistics and Machine Learning to detect signs of depression, as well as monitor whether […]

Revolab’s at-home blood testing digital platform is gaining momentum for expansion

Revolab, winner of the 2020 EIT Digital Venture Program, is ready to expand its at-home blood testing kit and platform across Europe following CE mark approval for its solution. In less than a year, the Lithuanian startup centered on self-monitoring of the user’s overall physical well-being has gone from inception to closing a seed round […]

PathAI raises $165 million in Series C funding round for its diagnostic and drug development software

Powered by machine learning and deep learning technologies, PathAI‘s solution not only identifies biomarkers of disease but is also able to predict responses to treatments, while continuously advancing and improving the work of pathologists and pharmaceutical researchers.  PathAI‘s promising solution has so far secured 3 multi-million funding rounds and is backed by industry-leading partners. Launched […]

Swedish group Doktor24 raises €40 million for European expansion and platform development

Doktor24 Group, consisting of digital health company Platform24 and care provider Doktor24, has announced that it has raised around €40m in a latest funding round that will allow it to expand in Europe and further develop its solution. Founded in 2016, the Stockholm-based group promised to create accessible and sustainable care with a focus on […]

Veri announces seed round of 4 million USD for further development of its solution to tackle metabolism issues

Earlier this month, Finnish healthtech Veri announced the successful closing of its 4 million USD seeding round. The round was led by PROFounders, and closely followed by Lifeline Ventures, Accel with angel investors like Johannes Schildt (CEO and co-founder of Kry/Livi) and Kristian Ranta (CEO and co-founder of Meru Health). While the round also includes […]

Eli Lilly partners with Roche, Dexcom, Glooko and others for diabetes-focused integrations

Earlier this month, Ely Lilly announced that diabetes management companies Dexcom, Glooko, myDiabby Healthcare and Roche will integrate the pharma giant’s Tempo pen and Tempo Smart Button into their respective software platforms and/or medical devices. These agreements will optimise the offering of the above-mentioned diabetes products and services, which will now be able to collect […]

Highlights: Caresyntax raises €83 million for surgical AI tool, InterSystems partners with Cognetivity and other latest news.

CARESYNTAX raises €83 million in a Series C funding round for the development of its AI-based surgical tool.  German healthtech company Caresyntax has raised €82.8 million in a Series C funding round. This latest round, led by PFM Health Sciences LP, Optum Ventures, Intel Capital and Lauxera Capital Partners, is one of the largest ever […]